Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-05-04 Sale |
2022-05-06 8:13 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
55,330 | $6.4685 | $357,900 | 18,002,176 (Indirect Direct) |
View |
| 2022-04-28 Sale |
2022-05-02 9:30 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
80,675 | $6.1405 | $495,381 | 19,174,770 (Indirect Direct) |
View |
| 2022-04-21 Sale |
2022-04-25 9:26 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
80,108 | $6.1701 | $494,275 | 26,290,299 (Indirect Direct) |
View |
| 2022-04-18 Sale |
2022-04-20 9:03 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
38,336 | $6.8302 | $261,842 | 10,185,580 (Indirect Direct) |
View |
| 2022-04-14 Sale |
2022-04-18 9:46 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
37,017 | $7.5541 | $279,630 | 10,223,916 (Indirect Direct) |
View |
| 2022-04-08 Sale |
2022-04-12 8:05 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
39,420 | $6.5954 | $259,991 | 10,260,933 (Indirect Direct) |
View |
| 2022-04-07 Sale |
2022-04-11 8:54 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
39,218 | $6.5409 | $256,520 | 10,300,353 (Indirect Direct) |
View |
| 2022-04-06 Sale |
2022-04-08 7:03 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
38,326 | $6.7609 | $259,119 | 10,321,071 (Indirect Direct) |
View |
| 2022-04-05 Sale |
2022-04-07 9:15 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
36,972 | $7.425 | $274,518 | 10,359,397 (Indirect Direct) |
View |
| 2022-03-11 Sale |
2022-03-15 8:57 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
336,150 | $6.4757 | $2,176,801 | 24,683,337 (Indirect Direct) |
View |
| 2022-03-07 Sale |
2022-03-09 8:44 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
300,000 | $7.2965 | $2,188,950 | 10,732,519 (Indirect Direct) |
View |
| 2022-02-22 Sale |
2022-02-24 7:24 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
100,000 | $10.22 | $1,021,540 | 11,032,519 (Indirect Direct) |
View |
| 2022-01-31 Sale |
2022-02-02 8:09 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
19,858 | $11.73 | $232,964 | 10,500,183 (Indirect Direct) |
View |
| 2022-01-13 Sale |
2022-01-14 8:42 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
341,000 | $13.76 | $4,692,177 | 26,671,725 (Indirect Direct) |
View |
| 2022-01-04 Sale |
2022-01-05 8:39 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
9,625 | $18.03 | $173,528 | 7,651,146 (Direct) |
View |
| 2021-12-21 Sale |
2021-12-23 5:05 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
9,625 | $18.75 | $180,478 | 7,660,216 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-05-16 Tax Withholding |
2022-05-18 7:15 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
1,458 | $5.67 | 206,560 (Direct) |
View |
| 2022-05-16 Tax Withholding |
2022-05-18 7:13 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,764 | $5.67 | 506,208 (Direct) |
View |
| 2022-05-04 Conversion |
2022-05-06 8:13 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
42,000 | $0 | 18,002,176 (Direct) |
View |
| 2022-05-04 Exercise |
2022-05-06 8:13 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 18,002,176 (Direct) |
View |
| 2022-05-04 Exercise |
2022-05-06 8:13 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 18,002,176 (Direct) |
View |
| 2022-04-28 Conversion |
2022-05-02 9:30 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
42,000 | $0 | 19,174,770 (Direct) |
View |
| 2022-04-28 Exercise |
2022-05-02 9:30 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
88,024 | $2.48 | 19,174,770 (Direct) |
View |
| 2022-04-28 Exercise |
2022-05-02 9:30 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
88,020 | $0 | 19,174,770 (Direct) |
View |
| 2022-04-21 Conversion |
2022-04-25 9:26 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
54,000 | $0 | 26,290,299 (Direct) |
View |
| 2022-04-25 Gift |
2022-04-25 9:26 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
12,000 | $0 | 26,290,299 (Direct) |
View |
| 2022-04-21 Exercise |
2022-04-25 9:26 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
88,020 | $2.48 | 26,290,299 (Direct) |
View |
| 2022-04-21 Exercise |
2022-04-25 9:26 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
88,020 | $0 | 26,290,299 (Direct) |
View |
| 2022-04-18 Conversion |
2022-04-20 9:03 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 10,185,580 (Direct) |
View |
| 2022-04-18 Exercise |
2022-04-20 9:03 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $2.48 | 10,185,580 (Direct) |
View |
| 2022-04-18 Exercise |
2022-04-20 9:03 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $0 | 10,185,580 (Direct) |
View |
| 2022-04-14 Conversion |
2022-04-18 9:46 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 10,223,916 (Direct) |
View |
| 2022-04-14 Exercise |
2022-04-18 9:46 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $2.48 | 10,223,916 (Direct) |
View |
| 2022-04-14 Exercise |
2022-04-18 9:46 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $0 | 10,223,916 (Direct) |
View |
| 2022-04-08 Conversion |
2022-04-12 8:05 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 10,260,933 (Direct) |
View |
| 2022-04-08 Exercise |
2022-04-12 8:05 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $2.48 | 10,260,933 (Direct) |
View |
| 2022-04-08 Exercise |
2022-04-12 8:05 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $0 | 10,260,933 (Direct) |
View |
| 2022-04-07 Conversion |
2022-04-11 8:54 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 10,300,353 (Direct) |
View |
| 2022-04-07 Exercise |
2022-04-11 8:54 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $2.48 | 10,300,353 (Direct) |
View |
| 2022-04-07 Exercise |
2022-04-11 8:54 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $0 | 10,300,353 (Direct) |
View |
| 2022-04-06 Conversion |
2022-04-08 7:03 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 10,321,071 (Direct) |
View |
| 2022-04-06 Exercise |
2022-04-08 7:03 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $2.48 | 10,321,071 (Direct) |
View |
| 2022-04-06 Exercise |
2022-04-08 7:03 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $0 | 10,321,071 (Direct) |
View |
| 2022-04-05 Conversion |
2022-04-07 9:15 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 10,359,397 (Direct) |
View |
| 2022-04-05 Exercise |
2022-04-07 9:15 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $2.48 | 10,359,397 (Direct) |
View |
| 2022-04-05 Exercise |
2022-04-07 9:15 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $0 | 10,359,397 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-05 7:26 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Bogue Zachary Director 10% Owner |
1,382 | $0 | 13,621,976 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-05 7:25 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
1,300 | $0 | 7,652,446 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-05 7:23 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
1,788 | $0 | 136,373 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-05 7:22 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | CHAVEZ R. MARTIN Director |
2,438 | $0 | 11,107 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-05 7:21 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
1,544 | $0 | 5,102,514 (Direct) |
View |
| 2022-03-31 Exercise |
2022-04-04 4:06 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
9,072 | $2.48 | 873,080 (Direct) |
View |
| 2022-03-31 Exercise |
2022-04-04 4:06 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
9,072 | $0 | 873,080 (Direct) |
View |
| 2022-03-11 Conversion |
2022-03-15 8:57 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
336,150 | $0 | 24,683,337 (Direct) |
View |
| 2022-03-07 Conversion |
2022-03-09 8:44 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
300,000 | $0 | 10,732,519 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 8:55 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
58,500 | $1.06 | 1,156,028 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 8:55 pm |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
58,500 | $0 | 1,156,028 (Direct) |
View |
| 2022-02-28 Exercise |
2022-03-01 8:00 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
15,625 | $2.48 | 873,080 (Direct) |
View |
| 2022-02-28 Exercise |
2022-03-01 8:00 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
15,625 | $0 | 873,080 (Direct) |
View |
| 2022-02-22 Conversion |
2022-02-24 7:24 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
100,000 | $0 | 11,032,519 (Direct) |
View |
| 2022-02-18 Exercise |
2022-02-22 7:58 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
16,000 | $1.06 | 1,156,028 (Direct) |
View |
| 2022-02-18 Exercise |
2022-02-22 7:58 pm |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
16,000 | $0 | 1,156,028 (Direct) |
View |
| 2022-02-14 Exercise |
2022-02-17 06:04 am |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
4,000 | $1.06 | 1,156,028 (Direct) |
View |
| 2022-02-14 Exercise |
2022-02-17 06:04 am |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
4,000 | $0 | 1,156,028 (Direct) |
View |
| 2022-02-04 Tax Withholding |
2022-02-08 9:11 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Corp. Dev. Officer |
1,114 | $11.4 | 878,097 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-08 9:11 pm |
N/A 2032-02-04 |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Corp. Dev. Officer |
128,829 | $0 | 878,097 (Direct) |
View |
| 2022-02-04 Tax Withholding |
2022-02-08 9:09 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
981 | $11.4 | 873,080 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-08 9:09 pm |
N/A 2032-02-04 |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
122,673 | $0 | 873,080 (Direct) |
View |
| 2022-02-04 Tax Withholding |
2022-02-08 9:07 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
678 | $11.4 | 3,030,682 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-08 9:07 pm |
N/A 2032-02-04 |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
180,897 | $0 | 3,030,682 (Direct) |
View |
| 2022-02-04 Tax Withholding |
2022-02-08 9:05 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
828 | $11.4 | 1,156,028 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-08 9:05 pm |
N/A 2032-02-04 |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
246,015 | $0 | 1,156,028 (Direct) |
View |
| 2022-02-04 Tax Withholding |
2022-02-08 9:03 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
343 | $11.4 | 11,132,519 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-08 9:03 pm |
N/A 2032-02-04 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
632,679 | $0 | 11,132,519 (Direct) |
View |
| 2022-01-31 Exercise |
2022-02-02 8:11 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
15,625 | $2.48 | 751,388 (Direct) |
View |
| 2022-01-31 Exercise |
2022-02-02 8:11 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
15,625 | $0 | 751,388 (Direct) |
View |
| 2022-01-31 Conversion |
2022-02-02 8:09 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
19,858 | $0 | 10,500,183 (Direct) |
View |
| 2022-01-13 Conversion |
2022-01-14 8:42 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
341,000 | $0 | 26,671,725 (Direct) |
View |
| 2021-12-28 Gift |
2022-01-14 8:42 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
75,000 | $0 | 26,671,725 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 8:48 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
40,322 | $2.47 | 750,000 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 8:48 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
40,322 | $0 | 750,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:46 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
659 | $0 | 5,100,970 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:45 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | HERSHBERG ROBERT Director |
693 | $0 | 7,862 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:43 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | CHAVEZ R. MARTIN Director |
1,040 | $0 | 8,669 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:41 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
763 | $0 | 134,585 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:39 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
555 | $0 | 7,651,146 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:38 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Bogue Zachary Director 10% Owner |
589 | $0 | 13,620,594 (Direct) |
View |